2CHYP Weekly Commentary
2 positions we are excited about in the near term Medical Properties Trust (MPW) has had strong fundamental growth each quarter which have gone unrecognized by the market due to various news items ranging from healthcare reform to one of its tenants struggling. The...read more
No reason volatility REIT prices have been moving around aimlessly on a paucity of fundamentally impactful news. Of particular note is the volatility in UMH Properties (UMH). Stock chart from SNL Financial As it surged up to nearly $15.00, we sold UMH in an attempt...read more
Overlooked news Medical Properties Trust (MPW) is issuing a Euro denominated senior note for 500mm Euros with a 3.325% coupon. This is fixed rate and matures in 2025. The market price did not move on the news, but its fundamentals did. This is a remarkably cheap...read more
Important Notes and Disclaimer
The information contained herein is confidential, privileged and only for the information of the intended recipient and may not be used, published or redistributed without the prior written consent of 2nd Market Capital Advisory Corporation (2MCAC).
Suitability. We cannot determine whether the portfolio holdings presented are suitable for any given reader. Readers are encouraged to contact their financial professional to discuss the suitability of any strategies or holdings prior to implementation in their portfolio.
Forward-looking statements. Commentary may contain forward-looking statements which are by definition uncertain. Actual results may differ materially from our forecasts or estimations, and 2MCAC cannot be held liable for the use of and reliance upon the opinions, estimates, forecasts, and findings in these documents.
Holdings. The specific securities identified and described herein do not represent all of the securities purchased or sold for advisory clients of 2MCAC. It should not be assumed that investments in the securities identified and described were or will be profitable. We do not intend presentation of 2CHYP's holdings as a recommendation, but rather as a statement of historical fact. It should not be assumed that purchases and sales made in the future will be profitable or will equal the performance of the securities in this list.
Past Performance does not guarantee future results. Investing in publicly held securities is speculative and involves risk, including the possible loss of principal. Historical returns should not be used as the primary basis for investment decisions. Although the statements of fact and data is this commentary have been obtained from sources believed to be reliable, 2MCAC does not guarantee their accuracy and assumes no liability or responsibility for any omissions/errors.
Benchmark Comparison. 2CHYP portfolio is compared to the I Shares REIT ETF (IYR) and Vanguard REIT ETF(VNQ) because these are common methods for investing in a portfolio of REITs and we view these as competitors or alternatives to 2CHYP. Both IYR and VNQ have fees that are factored into performance, while 2CHYP does not have a fee aside from trading commissions which are factored into performance. 2CHYP’s dividends are reinvested, while VNQ’s and IYR’s dividends are paid but not reinvested.
Expenses. Returns reflect the deduction of any transaction expenses. There are no costs or management fees charged nor deducted.
Calculation Methodology. Partial year return, unaudited. Dividends in 2CHYP are reinvested.
View disclosure information for 2nd Market Capital Advisory Corporation and our investment professionals by visiting the SEC Investment Advisor Public Disclosure website.
Copyright 2017 2MCAC | Website built and maintained by Zyte Site